india stocks posts
FeedPosted Jan 20th 2011 11:00AM by Steven Halpern (RSS feed)
Filed under: International Markets, India, Newsletters, Stocks to Buy
"Outsourcing play Cognizant Technology (CTSH) is a bet that after a strong 2010, this sector will continue to yield big profits for investors," says Nicholas Vardy.
The editor of Global Bull Market Alert explains, "CTSH, a New Jersey-based company with more than 75% of its 100,000-plus employees based in India, is set to continue performing well as the global economic recovery gains momentum.
"Cognizant does more than just staff low-end call centers, or process online catalog orders. Cognizant's workers test drugs, develop software and engage in a host of other sophisticated activities.
Continue reading India Outsourcing Boosts Cognizant (CTSH)
Posted Jun 21st 2010 11:10AM by Steven Halpern (RSS feed)
Filed under: International Markets, India, Newsletters, Stocks to Buy
"Modern drugs are expensive to develop; but after just 20 years, a drug can be duplicated by generic drug manufacturers and sold to those who need it for far less money," says Paul Goodwin.
The editor of Cabot China & Emerging Markets Report explains, "That's where Dr. Reddy's Laboratories (RDY) comes in. Founded in 1984 by Dr. Anji Reddy, Dr. Reddy's Labs is the main reason India has gone from a net drug importer to a net drug exporter.
"Dr. Reddy's is a growing global power in the pharmaceutical business, with a lineup of more than 50 products offered in the U.S., more than 160 products marketed in Europe, and more than 200 branded formulations available in India, Russia and other emerging markets.
Continue reading Dr. Reddy's (RDY): A 'Generic Revolution'
Posted Mar 19th 2010 1:00PM by Steven Halpern (RSS feed)
Filed under: India, Newsletters, Oil, Tata Mtrs Ltd (TTM), Stocks to Buy
"The Cabot China-Timer has flashed a new buy signal, telling us the trend of Chinese and emerging market stocks has turned back up. No one knows how long this signal will persist, and you shouldn't try to guess. Instead, your best move is to go with the evidence, which is now bullish," observes Paul Goodwin.
The editor of The Cabot China & Emerging Markets Report explains, "India's Tata Motors (TTM), the largest truck and auto maker in the subcontinent, has been a little of both over the years, but it looks like the time is right for a new advance.
Continue reading Tata Motors (TTM): Small Cars, Big Potential
Posted Jan 10th 2010 1:00PM by Steven Halpern (RSS feed)
Filed under: India, China, Newsletters, Commodities, Oil, Stocks to Buy, Best Stocks for 2010
This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.
"Peabody Energy (BTU), the world's largest coal producer, is my top pick for the coming year," says Hannah Choe.
The contributing analyst with Personal Finance explains, "Demand for coal, particularly from the Pacific Rim, China and India, is rebounding as the global economy recovers."
Continue reading Top Picks for 2010: Peabody Energy (BTU)
Posted Nov 9th 2009 1:40PM by Steven Halpern (RSS feed)
Filed under: India, China, Newsletters, Commodities, Oil, Stocks to Buy

"Peabody Energy (
BTU) remains a buy in our 'gushers portfolio'." says energy sector expert
Elliott Gue.
In his The Energy Strategist, he explains, "Strong demand for coal from India and China is a growth story that will play out in 2010."
Gue explains, "Peabody reported its third quarter results and share prices have reacted positively. The weakness in US coal markets remains a challenge, but Peabody has taken steps to shore up profitability in the US, cutting back planned production and locking in contracts for 2010 at fixed prices.
Continue reading Peabody (BTU): Energy expert looks to coal
Posted Oct 13th 2009 1:30PM by Steven Halpern (RSS feed)
Filed under: International Markets, India, Newsletters, Stocks to Buy
"The 'offshoring' of IT development, customer service and back office operations has always been controversial in the U.S. (because of the jobs lost)," observes Paul Goodwin.
In The Cabot China & Emerging Markets Report, he explains, "However, these outsourcing services have also been cost-effective. And outsourcing pioneer Wipro (NYSE: WIT) is very good at it.
"Wipro, the Indian megacap company, has been holding earnings steady as a rock despite the global recession that has ripped the heart out of so many companies.
Continue reading Wipro (WIT) and offshoring: Controvery and opportunity
Posted Aug 25th 2009 10:30AM by Steven Halpern (RSS feed)
Filed under: International Markets, India, Newsletters, Mutual Funds, ETF Investing, Stocks to Buy
"With an increasingly affluent middle class fueling heavy domestic consumption, India is teeming with investment opportunities," suggests Nathan Slaughter.
In The ETF Authority, he looks to Morgan Stanley India Investment (NYSE: IIF), noting, "This exchange-traded fund has been one of the best-performing Asian funds, quintupling shareholders' money during the past decade."
"India is home to 1.2 billion citizens, second only to China as the world's most populous nation. Many of its people still eke out a marginal, agrarian lifestyle. But, more than 300 million Indians are skilled workers that have graduated to the ranks of the middle and upper classes.
Continue reading Morgan Stanley India (IIF): 'Teeming with opportunity'
Posted Jul 16th 2009 1:00PM by Steven Halpern (RSS feed)
Filed under: International Markets, India, China, Newsletters, Stocks to Buy, China Mobile Limited (CHL)
"Inflationary fears and the desire to generate higher returns in non-dollar assets should boost BRIC stocks (Brazil, Russia, India and China)," says Chuck Carlson in his The DRIP Investor.
"Despite the run-up this year, BRIC stock markets are still reasonably valued. Russia, India, and Brazil all trade at price/earnings ratios similar to the U.S.
"And while China's stock market does trade at a premium to the U.S., China's economic growth will swamp that of the U.S. this year and for the foreseeable future.
Continue reading 'Compelling case' for China and India
Posted Jun 11th 2009 1:30PM by Steven Halpern (RSS feed)
Filed under: India, Newsletters, Stocks to Buy
"India-based Dr. Reddy's Laboratories (NYSE: RDY), a generic-drugs play with solid market positions in India, Russia, the US and Germany," says Asian stock expert Yiannis Mostrous.
In his specialty newsletter, The Silk Road Investor, he explains why he has chosen the firm as his latest "Stock of the month".
"Seventy percent of the firm's growth comes from generic drugs, and the trend there has been favorable. New products, market share gains and a revamp of the supply chain in India should contribute to profitability. The company is also building a proprietary pipeline to supplement it core business.
Continue reading Dr. Reddy's (RDY): Get ready for generic gains
Next Page >